Further studies to validate PRAME protein expression in glioma, using western blot analysis, immunohistochemistry, immunofluorescence, or other techniques, are needed because it is not clear whether PRAME gene expression can be an indicator of its protein status. This evidence concerns the gene PRAME and glioma.